Sichuan Goldstone Asia Pharmaceutical Inc.
SHZ: 300434.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Industrials
- Industry
- Industrial - Distribution
- CEO
- Yiping Ma
- Employees
- 1,937
- Headquarters
- Chengdu, China
- IPO year
- 2015
- Market cap
- CN¥4.7B
- Website
- https://www.goldstone-group.com
Loading 300434…
Loading profile data…Frequently asked questions about 300434
What does Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ) do?
Sichuan Goldstone Asia Pharmaceutical Inc. engages in the research, development, manufacture, and sale of medicines and health products in China and internationally. The company offers various pharmaceutical preparations and APIs; Chinese and western pharmaceutical preparations and raw materials; and tablets, capsules, dietary supplements, vitam...
Where does 300434.SZ trade?
Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300434.SZ in?
Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ) operates in the Industrials sector, specifically in the Industrial - Distribution industry.
Who is the CEO of Sichuan Goldstone Asia Pharmaceutical Inc.?
Yiping Ma is the chief executive officer of Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ).
Where is Sichuan Goldstone Asia Pharmaceutical Inc. headquartered?
Sichuan Goldstone Asia Pharmaceutical Inc. is headquartered in China.
Does 300434.SZ pay a dividend?
Yes — Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ) paid a trailing twelve-month dividend of CNY 0.07 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300434.SZ go public?
Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ) completed its initial public offering in 2015.